Abstract
The influence of pharmacological stimulation of pulmonary surfactant synthesis has been studied in rat alveolar spaces. Animals were treated acutely with Ambroxol at a dose of 4 mg/kg b.w./day p.o. and 5 days later the following biochemical and physico-chemical parameters were determined: BAL fluid lecithin content, BAL fluid microviscosity, alveolar macrophage membrane microviscosity, spontaneous generation of superoxide anion by alveolar macrophages, elastase and antielastase activity of BAL fluid. Treatment with Ambroxol significantly increased the lecithin content of BAL fluid and significantly decreased the macrophage plasma membrane microviscosity. A likely consequence of increased lecithin content in alveolar macrophages (an activation of these cells) was suggested by the increase of the spontaneous production of superoxide. Finally, in the BAL fluid of Ambroxol-treated rats the elastase activity was reduced, whereas the elastase inhibitory activity was almost doubled in respect to control rats.
Similar content being viewed by others
References
Allison AC (1974) Pathogenic effects of inhaled particles and antigens. Ann NY Acad Sci 221:299–308
Ando M, Suga M, Shima K, Sugimoto M, Tokuomi H (1978) Activation of alveolar macrophages exposed to lavage-procured immunoglobulin G obtained from normal rabbit lungs. Infect Immun 20:476–484
Ando M, Suga M, Sugimoto M, Tokuomi H (1979) Superoxide production in pulmonary alveolar macrophages and killing of BCG by the superoxide-generating system with or without catalase. Infect Immun 24:404–410
Bieth J, Spiesse B, Wermuth CG (1974) The synthesis and analytical use of a highly sensitive and convenient substrate of elastase. Biochem Med 11:350–357
Boraschi D, Ghezzi P, Salmona M, Tagliabue A (1982) IFN-γ-induced reduction of superoxide anion generation by macrophages. Immunology 45:621–628
Brot N, Werth J, Koster D, Weissbach H (1982) Reduction of N-acetyl methionine sulfoxide: a simple assay for peptide methionine sulfoxide reductase. Anal Biochem 122:291–294
Cantin A, Crystal RG (1985) Oxidants, antioxidants and the pathogenesis of emphysema. Eur J Respir Dis 66 (Suppl 139):7–17
Carp H, Janoff A (1980) Potential mediators of inflammation: phagocyte-derived oxidants suppress the elastase-inhibitory capacity of alpha 1-proteinase inhibitor in vitro. J Clin Invest 66:987–995
Carp H, Miller F, Hoidal R, Janoff A (1982) Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity. Proc Natl Acad Sci USA 779:2041–2045
Carp H, Janoff A, Abrams W, Weinbaum G, Drew RT, Weissbach H, Brot N (1983) Human methionine sulfoxide-peptide reductase, an enzyme capable of reactivating oxidized alpha-1-proteinase inhibitor in vitro. Am Rev Respir Dis 127:301–305
Cerutti P, Kapanci Y (1979) Effects of metabolite VIII of bromhexine (NA 872) on type II epithelium of the lung. Respiration 37:241–251
Claypool WD, Rogers RM, Matuschak GM (1984) Update on the clinical diagnosis, management, and pathogenesis of pulmonary alveolar proteinosis (phospholipidosis). Chest 85:550–558
Curstedt T, Hagman M, Robertson B, Camner P (1983) Rabbit lungs after long-term exposure low nickle dust concentration. I. Effects on phospholipids concentration and surfactant activity. Environ Res 30:89–94
Curti PC (1974) Therapeutische Untersuchungen mit metabolit VIII von bromhexin bei mangelhafter oberflachenaktiver substanz der alveolen. Arzneimittelforsch 24:847–849
Eckert H, Lux M, Lachmann B (1983) The role of alveolar macrophages in surfactant turnover. An experimental study with metabolite VIII of bromhexine (Ambroxol). Lung 161:213–218
Fasske E, Morgenroth K (1983) Experimental bleomycin lung in mice. A contribution to the pathogenesis of pulmonary fibrosis. Lung 161:133–146
Folch J, Lees M, Sloane-Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497–509
Golde DW, Territo M, Finley TM, Cline MJ (1976) Defective lung macrophages in pulmonary alveolar proteinosis. Ann Intern Med 85:304–309
Grunberger D, Haimovitz R, Shinitzky M (1982) Resolution of plasma membrane lipid fluidity in intact cells labelled with diphenylhexatriene. Biochim Biophys Acta 688:764–774
Harada RN, Repine JE (1985) Pulmonary host defense mechanisms. Chest 87:247–252
Harris GO (1979) Pulmonary alveolar proteinosis: abnormal in vitro function of alveolar macrophages. Chest 76:156–159
Hook GER, Gilmore LB (1982) Hydrolases of pulmonary lysosomes and lamellar bodies. J Biol Chem 257:9211–9220
Itoh T, Tanaka M, Kaneko H (1980) Flame ionization detection system for thin layer chromatography of lipids. In: Touchstone JC, Rogers D (eds) Thin layer chromatography. John Wiley & Sons, New York, pp. 536–552
Jarstrand C (1984) Role of surfactant in the pulmonary defense system. In: Robertson B, Van Golde LMG, Batenburg JJ (eds) Pulmonary surfactant. Elsevier Science Publishers, Amsterdam, pp. 187–201
Johansson A, Camner P, Jarstrand C, Wiernik A (1980) Morphology and function of alveolar macrophages after long-term nickel exposure. Environ Res 23:170–180
LaForce FM, Kelly WJ, Huber GL (1973) Inactivation of stafilococci by alveolar macrophages with preliminary observations on the importance of alveolar lining material. Am Rev Respir Dis 108:784–790
Lowry OK, Rosenbrough NJ, Farr AL, Randall RG (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Merritt TA, Cochrane CG, Holcomb K, Bohl B, Hallman M, Strayer D, Edwards DK III, Gluck L (1983) Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. J Clin Invest 72:656–666
O’Neill S, Lesperance E, Klass DJ (1984) Rat lung surfactant enhances bacterial phagocytosis and intracellular killing by alveolar macrophages. Am Rev Respir Dis 130:225–230
Prevost MC, Soula G, Douste-Blazy L (1978) Action d’un dérivé de la bromhexine sur les phospholipides des macrophages alvéolaires de lapin. Bull Europ Physiopath Resp 14:53–60
Reifenrath R (1983) Surfactant action in bronchial mucus transport. In: Cosmi EV, Scarpelli EM (eds) Pulmonary surfactant system. Elsevier Science Publishers, Amsterdam, pp. 339–347
Robertson B (1980) Interaction of pulmonary surfactant and alveolar macrophages in the nonspecific defence system of the lung. Eur J Respir Dis 61 (Suppl 108) 16–18
Rouzer CA, Scott WA, Griffith OW, Hamill AL, Cohn ZA (1982) Glutathione metabolism in resting and phagocytosing peritoneal macrophages. J Biol Chem 247:2002–2008
Scarpelli EM (1968) The surfactant system of the lung. Lea and Febiger, Philadelphia
Shinitzky M, Barenholz Y (1978) Fluidity parameters of lipid regions determined by fluorescence polarization. Biochim Biophys Acta 515:367–394
Author information
Authors and Affiliations
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/BF02714039.
Rights and permissions
About this article
Cite this article
Luisetti, M., Salmona, M., Pozzi, E. et al. In vivo studies of rat alveolar macrophase microviscosity: Influence of pulmonary surfactant synthesis stimulation. Lung 165, 333–340 (1987). https://doi.org/10.1007/BF02714449
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02714449